ArticleJournal of clinical biochemistry and nutrition2023

Knockdown of LRRK2 inhibits the progression of lung cancer by regulating TLR4/NF-κB pathways and NLRP3 inflammasome.

Junfang Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.